An immunohistochemical study of the ontogeny of the horizontal cell in the rat retina using an antiserum against spot 35 protein, a novel Purkinje cell-specific protein, as a marker.
A sequence of morphological changes during the differentiation of retinal horizontal cells was studied by means of immunohistochemistry for spot 35 protein, a novel Purkinje cell-specific protein, in the rat retina. Spot 35-immunoreactive horizontal cell anlagen were first identified at embryonic day 18 (E18) in the outer zone of the neuroblastic cell layer as fusiform cells with slender inner and outer processes. As the development proceeded, the immunoreactive cells increased in number and intensity of the immunostaining, and the outer processes of the immunoreactive cells were often bifurcated close to their origin or at their periphery. At postnatal days 3 and 5 (P3 and P5), a regional difference in morphology of the immunoreactive horizontal cell anlagen was recognized: The immunoreactive cells near the ora serrata still assumed a bipolar shape, and those in the central portion of the retina had multiple processes. At P7 and P10, the immunoreactive cells in the periphery of the retina extended most of their outer processes in the plane of the retina, forming a network together with processes of adjacent immunoreactive horizontal cells. Their internally extending processes during these postnatal stages tended to be present in small numbers and to be short. At P14 all the immunoreactive horizontal cells extended their processes horizontally to form a tight bundle all the way along the outer plexiform layer. These findings indicate that spot 35 protein is a specific marker for the horizontal cells of the rat retina in the developmental process from their bipolar stage at E18 until reaching their mature configuration at P14.
Kondo
H
H
Department of Anatomy, School of Medicine, Kanazawa University, Japan.
Yamamoto
M
M
Yamakuni
T
T
Takahashi
Y
Y
D000818:Animals; D015415:Biomarkers / Q000032:analysis; D064092:Calbindin 1; D064026:Calbindins; D002135:Calcium-Binding Proteins; D002460:Cell Line; D005260:Female; D007106:Immune Sera / Q000276:immunology*; D007150:Immunohistochemistry; D008297:Male; D009419:Nerve Tissue Proteins / Q000276:immunology* / Q000378:metabolism; D011689:Purkinje Cells / Q000378:metabolism*; D051381:Rats / Q000033:anatomy & histology*; D012160:Retina / Q000166:cytology*; D064030:S100 Calcium Binding Protein G
D015415:Biomarkers; C576500:Calb1 protein, rat; D064092:Calbindin 1; D064026:Calbindins; D002135:Calcium-Binding Proteins; D007106:Immune Sera; D009419:Nerve Tissue Proteins; D064030:S100 Calcium Binding Protein G